Ezetimib-Rosuvastatin-Mepha
Ezetimib-Rosuvastatin-Mepha is an originator product from Mepha Pharma AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 39.55 to CHF 124.65 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- Mepha Pharma AG
- ATC code
- C10BA06
- IT group
- 07.12 Blutlipidsenkende Mittel
- Active substances
- Ezetimibum, Rosuvastatinum
- Preparation type
- Originator product
- On the SL since
- 01/05/2023
- Last price change
- 01/10/2025
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Filmtabl 10mg/5 mg | Blist 30 Stk | CHF 21.27 | CHF 39.55 | 01/05/2023 | B | 7680684370014 |
| Filmtabl 10mg/5 mg | Blist 90 Stk | CHF 63.81 | CHF 85.80 | 01/05/2023 | B | 7680684370021 |
| Filmtabl 10mg/10 mg | Blist 30 Stk | CHF 25.05 | CHF 43.65 | 01/05/2023 | B | 7680684370038 |
| Filmtabl 10mg/10 mg | Blist 90 Stk | CHF 75.15 | CHF 98.15 | 01/05/2023 | B | 7680684370045 |
| Filmtabl 10mg/20 mg | Blist 30 Stk | CHF 28.83 | CHF 47.75 | 01/05/2023 | B | 7680684370052 |
| Filmtabl 10mg/20 mg | Blist 90 Stk | CHF 86.50 | CHF 110.50 | 01/05/2023 | B | 7680684370069 |
| Filmtabl 10mg/40 mg | Blist 30 Stk | CHF 33.18 | CHF 52.50 | 01/10/2025 | B | 7680684370076 |
| Filmtabl 10mg/40 mg | Blist 90 Stk | CHF 99.54 | CHF 124.65 | 01/10/2025 | B | 7680684370083 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
More preparations in this group
FAQ
Is Ezetimib-Rosuvastatin-Mepha covered by Swiss health insurance?
Yes, but only under conditions. Ezetimib-Rosuvastatin-Mepha is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Ezetimib-Rosuvastatin-Mepha cost in Switzerland?
The public price is the maximum price set by the FOPH and for Ezetimib-Rosuvastatin-Mepha ranges from CHF 39.55 to CHF 124.65 per pack. The ex-factory price ranges from CHF 21.27 to CHF 99.54. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages